<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
MYGN
Myriad Genetics
$
()


  • Myriad reports results from real-world study of patients with depression

    4/9/2024 - 08:29am
  • Myriad Genetics issued patent for MRD

    3/22/2024 - 05:23am
  • Myriad Genetics announces patent granted for SneakPeek Snap device

    3/20/2024 - 16:20pm
  • Myriad Genetics price target raised by $3 at Raymond James, here's why

    2/28/2024 - 09:16am
  • Myriad Genetics price target raised by $3 at TD Cowen, here's why

    2/28/2024 - 07:23am
  • Myriad Genetics price target raised by $3 at JPMorgan, here's why

    2/28/2024 - 06:58am
  • Myriad Genetics sees FY24 adjusted EPS 0c-5c, consensus (1c)

    2/27/2024 - 16:58pm
  • Myriad Genetics, NCCHE collaborate on SCRUM-MONSTAR-SCREEN-3 study

    2/27/2024 - 09:16am
  • Myriad Genetics management to meet with BTIG

    2/12/2024 - 16:25pm
  • Myriad Genetics management to meet with BTIG

    2/12/2024 - 04:55am
  • Myriad Genetics management to meet with BTIG

    2/5/2024 - 07:50am
  • Myriad Genetics completes asset acquisition from Intermountain Health

    2/1/2024 - 09:28am
  • Myriad Genetics names George Daneker as Chief Clinical Officer of Oncology

    1/30/2024 - 17:01pm
  • Myriad Genetics signs agreement to acquire certain assets from Intermountain

    1/18/2024 - 18:12pm
  • Mesa Labs appoints Mark Capone to board of directors

    1/8/2024 - 08:28am
dynamic_feed Breaking News